2 results match your criteria: "China. jiang.lindi@zs-hospital.sh.cn.[Affiliation]"
Curcumin alleviates inflammation in Takayasu's arteritis by blocking CCL2 overexpression in adventitial fibroblasts.
Clin Exp Rheumatol
May 2021
Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, and Evidence-Based Medicine Centre, Fudan University, Shanghai, China.
Objectives: Takayasu's arteritis (TAK) is a chronic inflammatory disease with several challenges in treatment. Curcumin is known for its anti-inflammatory effects, whereas its effect in the treatment of TAK remains unclear. In this study, we aimed to investigate the effect of curcumin in the treatment of TAK and its underlying mechanisms.
View Article and Find Full Text PDFSerum complement 3 is a potential biomarker for assessing disease activity in Takayasu arteritis.
Arthritis Res Ther
February 2021
Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Background: Takayasu arteritis (TA) is a rare disease, lacking convenient and feasible biomarkers to identify disease activity. We aimed to evaluate the value of complements in distinguishing active TA.
Methods: Consecutive patients were enrolled from the prospective East China TA cohort from April 2008 to June 2019.